BridgeBio has substantially improved this course of an innovative solution for ATTR-CM, leveraging the compound. Preliminary trial results suggests significant benefits for individuals suffering from a severe illness. The focus represents researchers’ focus to treating significant healthcare needs in this cardiology arena. Attruby: BridgeBio's N